181 related articles for article (PubMed ID: 14983023)
1. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.
Rooney S; Sekiguchi J; Whitlow S; Eckersdorff M; Manis JP; Lee C; Ferguson DO; Alt FW
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2410-5. PubMed ID: 14983023
[TBL] [Abstract][Full Text] [Related]
2. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.
Difilippantonio MJ; Petersen S; Chen HT; Johnson R; Jasin M; Kanaar R; Ried T; Nussenzweig A
J Exp Med; 2002 Aug; 196(4):469-80. PubMed ID: 12186839
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.
Wang JH; Alt FW; Gostissa M; Datta A; Murphy M; Alimzhanov MB; Coakley KM; Rajewsky K; Manis JP; Yan CT
J Exp Med; 2008 Dec; 205(13):3079-90. PubMed ID: 19064702
[TBL] [Abstract][Full Text] [Related]
4. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
5. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.
Zhu C; Mills KD; Ferguson DO; Lee C; Manis J; Fleming J; Gao Y; Morton CC; Alt FW
Cell; 2002 Jun; 109(7):811-21. PubMed ID: 12110179
[TBL] [Abstract][Full Text] [Related]
6. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
7. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination.
Franco S; Murphy MM; Li G; Borjeson T; Boboila C; Alt FW
J Exp Med; 2008 Mar; 205(3):557-64. PubMed ID: 18316419
[TBL] [Abstract][Full Text] [Related]
8. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
[TBL] [Abstract][Full Text] [Related]
9. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
[TBL] [Abstract][Full Text] [Related]
10. The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity.
Woo Y; Wright SM; Maas SA; Alley TL; Caddle LB; Kamdar S; Affourtit J; Foreman O; Akeson EC; Shaffer D; Bronson RT; Morse HC; Roopenian D; Mills KD
Oncogene; 2007 Sep; 26(41):6010-20. PubMed ID: 17384673
[TBL] [Abstract][Full Text] [Related]
11. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
12. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
13. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms that can promote peripheral B-cell lymphoma in ATM-deficient mice.
Tepsuporn S; Hu J; Gostissa M; Alt FW
Cancer Immunol Res; 2014 Sep; 2(9):857-66. PubMed ID: 24913718
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal location targets different MYC family gene members for oncogenic translocations.
Gostissa M; Ranganath S; Bianco JM; Alt FW
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
[TBL] [Abstract][Full Text] [Related]
16. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.
Franco S; Gostissa M; Zha S; Lombard DB; Murphy MM; Zarrin AA; Yan C; Tepsuporn S; Morales JC; Adams MM; Lou Z; Bassing CH; Manis JP; Chen J; Carpenter PB; Alt FW
Mol Cell; 2006 Jan; 21(2):201-14. PubMed ID: 16427010
[TBL] [Abstract][Full Text] [Related]
17. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
[TBL] [Abstract][Full Text] [Related]
18. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice.
Gladdy RA; Taylor MD; Williams CJ; Grandal I; Karaskova J; Squire JA; Rutka JT; Guidos CJ; Danska JS
Cancer Cell; 2003 Jan; 3(1):37-50. PubMed ID: 12559174
[TBL] [Abstract][Full Text] [Related]
19. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.
Ramiro AR; Jankovic M; Callen E; Difilippantonio S; Chen HT; McBride KM; Eisenreich TR; Chen J; Dickins RA; Lowe SW; Nussenzweig A; Nussenzweig MC
Nature; 2006 Mar; 440(7080):105-9. PubMed ID: 16400328
[TBL] [Abstract][Full Text] [Related]
20. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene.
Akasaka T; Akasaka H; Ueda C; Yonetani N; Maesako Y; Shimizu A; Yamabe H; Fukuhara S; Uchiyama T; Ohno H
J Clin Oncol; 2000 Feb; 18(3):510-18. PubMed ID: 10653866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
